Close
Novotech
Jabsco PureFlo 21 Single Use

Clinical Trials

Randomized Trials Backed By FDA For Speedy Drug Approvals

In a significant update to its existing policies when it comes to conducting clinical trials so as to support an accelerated approval for oncology as well as other life-saving therapies, the FDA is planning a preference for randomised controlled...

Bladder Cancer Can Gain From Sustained-Release Chemotherapy

As reported by a study, a novel, sustained-release chemotherapy delivery device which is inserted in the bladder has gone on to facilitate the tumour response. The treatment was given to patients in the elderly bracket who had advanced bladder...

UK To Give Faster Clinical Trial Nods Following Setbacks

The UK government intends to make clinical trials more accessible in order to re-establish the country's reputation as a favoured location for pioneering research. In a new initiative to jump-start the country's faltering life sciences goals, the Medicines and Healthcare...

4-Year Study On Cystic Fibrosis Patients Shows Efficacy

The combination of modulator therapies tezacaftor (TEZ) and ivacaftor (IVA) for cystic fibrosis (CF) has shown long-term safety as well as clinical benefit in a trial that lasted four years. Both the CF modulators were assessed across the age group...

$15m Mitochondrial Clinical Trial Headed by Australian University

Almost 50 children in Australia are born every year with a devastating mitochondrial disease that has an expected lifespan of just 5 years. In a first in Australia, the Medical Research Future Fund has gone on to announce $15...

Intracranial Pressure Reduced Through Injectable Peptide

It has come to light that patient with idiopathic intracranial hypertension- IIH can be treated with an injectable peptide used for type 2 diabetes. This has been found in a Phase II trial. As per the study’s latest findings,...

Greenphire Expands Agreement with Merck to Help Reduce Financial and Travel Barriers for Clinical Trial Participants Worldwide

Greenphire, the global leader in financial lifecycle management for clinical trials, today announced an expansion of its agreement with Merck, known as MSD outside the United States and Canada. This expanded agreement now includes the use of Greenphire's ClinCard...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »